Long-term treatment of T2DM obese ZSF1 rats with another BAS, SAR442357, increased plasma insulin levels and decreased HbA1c, cholesterol, and triglyceride levels (Supplementary Table S1). Here, INS is linked to type 2 diabetes mellitus.